SEARCH

SEARCH BY CITATION

Keywords:

  • lactobacilli;
  • mechanism;
  • mucosal immune system;
  • probiotics;
  • systemic immune system

Summary

  1. Top of page
  2. Summary
  3. Introduction
  4. Mucosal immune system
  5. Systemic immune system
  6. Effect of probiotic lactobacilli in challenge with pathogens
  7. Use of lactobacilli as a delivery vehicle for antigens in immunization protocols
  8. Conclusion
  9. Acknowledgements
  10. Conflict of Interest
  11. References

The mechanism by which probiotic lactobacilli affect the immune system is strain specific. As the immune system is a multicompartmental system, each strain has its way to interact with it and induce a visible and quantifiable effect. This review summarizes the interplay existing between the host immune system and probiotic lactobacilli, that is, with emphasis on lactobacilli as a prototype probiotic genus. Several aspects including the bacterial-host cross-talk with the mucosal and systemic immune system are presented, as well as short sections on the competing effect towards pathogenic bacteria and their uses as delivery vehicle for antigens.


Introduction

  1. Top of page
  2. Summary
  3. Introduction
  4. Mucosal immune system
  5. Systemic immune system
  6. Effect of probiotic lactobacilli in challenge with pathogens
  7. Use of lactobacilli as a delivery vehicle for antigens in immunization protocols
  8. Conclusion
  9. Acknowledgements
  10. Conflict of Interest
  11. References

The concept of probiotics probably dates back to 1908, when Noble Prize Winner Eli Metchnikoff suggested that the long life of Bulgarian peasants resulted from their consumption of fermented milk products. The term ‘probiotic’ was first used in 1965, by Lilly and Stillwell for describing substances secreted by one organism which stimulate the growth of another (Gupta and Garg 2009). The term was derived from the Greek word, meaning ‘for life’ (Reid et al. 2003). In a broadened definition, Naidu et al. (1999) describes probiotics as microbial dietary adjuncts that beneficially affect the host physiology by modulating the immune system as well as improving nutritional and microbial balance in the intestinal tract. An expert panel commissioned by FAO (Food and Agriculture Organization of the United Nations) and WHO (World Health Organizations) defined probiotics as ‘live micro-organisms’ which, when administered in adequate amounts, confers a health benefit on the host (FAO/WHO 2001). Marteau et al. (2002) defined them as ‘microbial preparation or components of microbial cells that have a beneficial effect on health and well-being’. Nowadays, the mainly accepted definition states probiotics should be live micro-organisms.

The immune system can be divided into two general arms: innate (natural or nonspecific) and adaptive (acquired or specific) immunity, which work together synergistically (Cummings et al. 2004). In mammals, it has an extremely sophisticated adaptive immune arm of both systemic and mucosal (local) type, where a complex array of cells and molecules interacts to provide protection from challenge by pathogenic microbes (bacteria, viruses, parasites). In vitro experiments and studies with germ-free animals have convincingly demonstrated that a healthy intestinal microbiota mediates important roles in normal gut regulation and homeostasis, influencing epithelial growth and survival, innate and adaptive immune development and regulation, competitive exclusion of pathogens (Bienenstock et al. 2013). During their interaction with the host, probiotics forming microbiota perform in different manners and affect several parts of the host immune system. Therefore, the use of Lactobacillus as probiotic for human requires fine-tuned selection of biologically relevant strains and a comprehensive understanding of its action on immune system elements. This review explores in a multidimensional way, how probiotic especially lactobacilli strains stimulate mucosal and systemic immune system to thoroughly elucidate the mechanism of action.

Mucosal immune system

  1. Top of page
  2. Summary
  3. Introduction
  4. Mucosal immune system
  5. Systemic immune system
  6. Effect of probiotic lactobacilli in challenge with pathogens
  7. Use of lactobacilli as a delivery vehicle for antigens in immunization protocols
  8. Conclusion
  9. Acknowledgements
  10. Conflict of Interest
  11. References

The mucosal surfaces include the surface lining of the gastrointestinal, respiratory and genitourinary tracts, where the encounters with antigens or infectious agents occur (Delves and Roitt 2000). Mammals have developed an extremely sophisticated adaptive immune system of both systemic and mucosal (local) type. The immune properties of the digestive mucosa are provided by the GALT (gut-associated lymphoid tissue), composed of lymphoid aggregates, including the Peyer's patches (located mainly in the small intestinal distal ileum), where induction of immune response occurs, and mesenteric lymphoid nodes (Izcue et al. 2009). The mucosal immune system also consists of physical (mucus), molecular (antimicrobial proteins) and cellular components that act synergistically to prevent microbes from invading the body. Epithelial cells have long been understood as a primary physical barrier, forming a selective cellular barrier, and are now recognized as a principal interface with the microbiota, initiating immune responses (Koch and Nusrat 2012). The probiotics are clearly involved in the anatomic and functional development of mucosal immunity mediated by intraepithelial lymphocytes and other immunomodulatory cells (cytokine-producing cells, phagocytic cells, goblet cells, IgA-secreting cells) resident in the mucosal lamina propria (Fig. 1). Many probiotic strains, upon adherence and colonization of the gut, (Lebeer et al. 2008) can manipulate the host's mucosal immune system through secretion of ‘immunomodulins’ that affect cell signalling pathways in mammalian cells (Hemaiswarya et al. 2013). Some of these effects are direct on immune cells such as dendritic cells (DC) which can themselves protrude through intact epithelial tight junctions and sample luminal contents and even engulf bacteria. Using an intestinal loop mouse model and fluorescently labelled bacteria, it was proven that entry of commensal or probiotic bacteria in Peyer's patches (PP) via the microfold cell pathway was mediated by their association with S-IgA (Rol et al. 2012). Other probiotic bacteria promote the generation and up-regulation of regulatory DC and T cells and this is associated with increased production of the regulatory cytokines TGFβ and especially IL-10 (Bienenstock et al. 2013). This part will delineate the effects of lactobacilli on different compartments of intestinal mucosal immune system.

image

Figure 1. Overview of effects of probiotic lactobacilli on mucosal and systemic immune systems. This figure summarizes the evidences collected from published articles showing the immune compartments affected by probiotic lactobacilli at mucosal and systemic level. In the intestinal fluid, probiotics influence the production of AMPs by Paneth cells, the production of mucus by goblets cells as well as the level of secretory IgA that is under the dependence of APRIL produced by IEC. Probiotics affects the expression level of TLRs on DC as wells as immune cells in Peyer's patches, leading to a production of a wide range of cytokine regulating the evolvement of immune response. Through lymph nodes, immune cells can migrate from lamina propria to circulation, therefore influencing the systemic immune system. This can be noticed by the influence on IgA, IgG levels in serum and the range of cytokines produced by PBMC. The immune cells in spleen are also influenced by probiotics, that is remarked by the variation in cytokines production and stimulation of specific population of lymphocytes. The diverse patterns observed when using probiotics as immunomodulators can be explained by the composition of TA and LTA that varies from strain to strain. [UPWARDS ARROW], Increase; [DOWNWARDS ARROW], Decrease; AMPs, Antimicrobial peptides; APRIL, A proliferation-inducing ligand; B, Lymphocyte B; DC, Dendritic cells; IEC, Intestinal epithelial cells; IgA, IgG, Immunoglobulin A, G; IgA+, IgA-producing cells; IL-1,2, etc., Interleukins 1, 2, etc.; LTA, Lipoteichoic acid; M, Macrophages; Mo, Monocytes; N, Neutrophils; NK, Natural killer; PBMC, Peripheral blood mononuclear cells; RBC, Red blood cells; S-IgA, Secretory IgA; T, Lymphocyte T; TA, Teichoic acid; TGF-β, Transforming growth factor beta; Th1, Lymphocyte T helper producing cytokines inducing cell-mediated immune response; Th2, Lymphocyte T helper producing cytokines inducing humoral-mediated immune response; TLC and DLC, Total and differential leucocyte count; TLRs, Toll like receptors; TNFα, Tumour necrosing factor alpha; Treg, Lymphocyte T helper producing regulatory cytokines.

Download figure to PowerPoint

Effects on secretory-IgA levels and IgA-secreting cells

In the lamina propria of the gut, B cells differentiate into plasma cells and secrete dimeric IgA antibodies. The polymeric Ig receptor (pIgR) on the basolateral surface of intestinal epithelial cells complexes with IgA and transports it to the apical cell surface where it is secreted into the intestinal lumen (Peterson et al. 2007). Secretory IgA is multifunctional in mucosal-associated immunity. It helps protecting the host by binding a variety of antigens (bacteria, virus, fungi, etc.) thus avoiding opportunistic pathogens to enter and disseminate in the systemic compartment (a process known as immune exclusion). In addition, it assists in controlling the necessary symbiotic relationship existing between commensals and the host (Corthesy 2013). S-IgA fulfils its function at mucosal surface by sampling of antigen-S-IgA complexes by microfold (M) cells, intimate contact occurring with Peyer's patch dendritic cells (DC), down-regulation of inflammatory processes, modulation of epithelial cells and clearing of immune complex by peristalsis (Corthesy 2013).

There is evidence that probiotic lactobacilli affect the IgA secretion in intestinal fluid and the number of IgA-secreting cells. For instance, Lactobacillus casei Zhang (Ya et al. 2008) and Lactobacillus crispatus KT-11 (Tobita et al. 2010) have shown the ability to improve the gastrointestinal mucosal resistance to infections by inducing a substantial increase in the concentration of S-IgA in intestinal fluid in a dose-dependent manner compared with control. Similarly, the number of IgA-secreting cells in lamina propria of small intestine increased significantly 7 days after the administration of Lact. casei CRL 431, but the intestinal fluid did not contain specific S-IgA against the probiotic culture epitopes, suggesting that there was no antigen presentation of Lact. casei epitope to Th-2 cells after 7 days of administration (Maldonado and Perdigon 2006). Even after a long-term (98 days) oral administration of fermented milk containing Lact. casei DN-114001, Lactobacillus delbrueckii ssp. bulgaricus and Streptococcus thermophilus, the numbers of IgA+ cells in both the small and large intestine increased (De Moreno de LeBlanc et al. 2008) as well as in mucosal sites distant to the gut such as bronchus and mammary gland, by migration of the IgA+ cells to the mesenteric lymphoid node and then via the thoracic duct to the circulation, arriving in the bronchus and mammary glands (Galdeano et al. 2007; De Moreno de LeBlanc et al. 2008). The mechanism underlying is not yet clear but it has been proven that epithelial cells and DCs, under stimulation of probiotic or microbiota, produce molecules such as A Proliferation-Inducing Ligand (APRIL), CD40 ligand and TGF-β that induce T cell-independent IgA class switching (Peterson et al. 2007). Lactobacillus plantarum NCIMB88 and Lact. plantarum WCFS1 induced Intestinal Epithelial Cells (IECs) to produce APRIL, which triggers IgA class switching to IgA2, an immunoglobulin more resistant to bacterial protease (Peterson et al. 2007).

Effects on cytokine-producing cells

The most fascinating feature and extensively studied effect of immune system modulation by probiotic bacteria is cytokine production. Probiotic bacteria induce the secretion of cytokines from IEC in a strain-specific manner. Moreover, the same cytokine can be produced by multiple cell types; can have multiple effects on the same cell and act on many different cell types (Ashraf and Shah 2014). IECs are the initial point of contact between the host and intestinal microbes and they communicate extensively with commensal bacteria and probiotics, influencing the inflammatory signalling pathway in IECs. The key signalling channel is the nuclear factor-kappa B (NF-ĸB) pathway. Under nonstimulatory conditions, NF-κB is present in its inactive form in the cytoplasm, bound to the inhibitor molecule, the inhibitor of NF-κB (IκB). When pro-inflammatory stimuli trigger signalling pathways, IκB is phosphorylated by IκB kinase (IKK), targeting it for ubiquitination and subsequent proteasomal degradation. Once freed from IκB, NF-κB is able to migrate into the nucleus, bind target promoters and activate transcription of effector genes like pro-inflammatory genes (Thomas and Versalovic 2010). Several probiotic strains can prevent degradation of IκB, therefore preventing the expression of pro-inflammatory cytokine like IL-8 by IEC (Thomas and Versalovic 2010). A study by Zhang et al. (2005), investigating the effects of both viable and heat-killed Lactobacillus GG in an epithelial cell model, demonstrated the probiotic's ability to decrease IκB degradation and subsequent NF-κB translocation into the nucleus, resulting in decreased TNF-induced IL-8 production (Zhang et al. 2005). Others have shown that pretreatment of epithelial cells with Lact. casei DN-114 001 decreased Shigella flexneri-induced NF-κB activation due to inhibition of IκBα degradation (Tien et al. 2006).

The anti-inflammatory role of IL-6 in the enhancement of IgA secretion has been well demonstrated. This cytokine produced by IEC, macrophages and T cells, has the ability to induce the terminal development of B cells in plasmatic cells, which express IgA (Goodrich and McGee 1999). Maldonado and Perdigon (2006) found an intercorrelation between the increase in IL-6-producing cells and IgA-secreting cells in lamina propria of mice 7 days after administration of Lact. casei CRL 431. Mast cells also stimulated by probiotic, can produce the cytokine IL-4, which together with IL-6 and TGF-β, induce the T-independent switch from IgM to IgA on the surface of B lymphocytes, thereby enhancing the production of IgA (Galdeano et al. 2007). The preferential switching to IgA could also be explained by the fact that bacterial and food-derived products present in the gut (lipopolysaccharide and retinoic acid) condition Follicular DCs and facilitate the activation of TGF-β1 and secretion of large amounts of B-cell activating factor (BAFF) (Suzuki et al. 2010; Macpherson et al. 2012), the two essential cytokines that direct switching towards IgA and survival of recently switched IgA+ B cells, respectively (Kato et al. 2014). In a recent study, a low dose (106 CFU ml−1) of Lactobacillus acidophilus NCFM significantly promoted IFN-γ-producing T cell responses and down-regulated T-regulatory (Treg) cell responses and their TGF-β and IL-10 productions in intestine and spleen, compared with the high dose (109 CFU ml−1) and control groups (Wen et al. 2012a). Conversely, high dose increased the frequency of Treg cells in most of the tissues compared with the control groups (Wen et al. 2012a). This study therefore suggests that Lact. acidophilus NCFM can be ineffective or even detrimental if not used at the optimal dosage for the appropriate purposes. Further work needs to be performed on other probiotics to determine more fully the effects of different doses.

Dendritic cells (DCs) directly sample gut luminal contents through cellular processes that extend between IEC into the lumen. This feature of intestinal DCs, combined with their ability to orchestrate T-lymphocyte responses, highlights the role of DCs as a bridge between microbes, innate immunity and adaptive immunity (Thomas and Versalovic 2010). Intestinal DCs can harbour viable commensal bacteria and transport the bacteria to the mesenteric lymph nodes (MLNs) through M Cells, where it is retained and prevented from entering the systemic immune compartment (Rochereau et al. 2013). By this mechanism, DCs can selectively induce IgA to protect against mucosal invasion, while restricting immune responses to the local microbial community in the gut (Macpherson et al. 2005).

It has been shown that different species of Lactic Acid Bacteria (LAB) possess the ability to finely regulate DC maturation and their interactions with Natural Killer (NK) cells, polarizing the subsequent T cell activity towards Th1, Th2 or even Treg responses (Fink et al. 2007). This network can, therefore, control not only the strength and the quality of innate responses, but also the subsequent adaptive responses, via both cell-to-cell interactions and cytokine release (Rizzello et al. 2011). A study on the dose-dependent immunomodulation of human DCs by the probiotic Lactobacillus rhamnosus Lcr35 showed that very different profiles of gene expression were induced with different doses, displaying pro- or anti-inflammatory profiles (Evrard et al. 2011). The glycosylation of the S-layer protein produced by Lact. acidophilus NCFM is considered to be a key step for its interaction with the C-type Lectin Receptors DC-SIGN (DC-specific ICAM3-grabbing nonintegrin) and influences cytokine response in DCs and T cell priming (Konstantinov et al. 2008).

The impact of bacterial growth stage on host communication has been clearly demonstrated by the substantially different effects elicited in the intestine mucosa by exponentially growing vs stationary phase derived from Lact. plantarum bacteria. The Lact. plantarum preparations derived from the stationary phase of growth have been found to stimulate prominently immune pathways, although this has not been observed by logarithmically growing bacteria of the same strain (van Baarlen et al. 2009). Some probiotic strains may also stimulate regulatory immune mechanisms by the generation of regulatory DCs and CD4+Foxp3+ T cells (Kwon et al. 2010). However, it remains unclear whether the mechanism involves Microbe-Associated Molecular Pattern (MAMP)-mediated Toll like Receptor (TLR) signalling on Treg cells, DCs or IECs. But after their activation by Antigen Presenting Cells (APCs), Treg cells migrate in MLN via lymphatics, presumably in an S1P receptor 1-dependent process and feedback on immune induction at the systemic level (Pabst 2013).

Effects on TLRs expression in lamina propria and Peyer's patches

Another fundamental property of the epithelia is its ability to monitor bacterial presence, which is generally recognized to involve host perception of prokaryotic macromolecular motifs (such as LPS, peptidoglycan and flagellin) that are bound and recognized by pattern recognition receptors (PRRs), such as TLRs and Nod (Nucleotide oligomerization domain) proteins (Pedron and Sansonetti 2008). These macromolecules, designated MAMPs, are generally invariant structural components of the bacteria, including specific cell wall polysaccharides, peptidoglycan (PG), lipoprotein anchors, lipoteichoic acids (LTA) anchored in the cytoplasmic membrane, wall bound teichoic acids (WTA) and polysaccharides (Van Baarlen et al. 2013). MAMP bound PRRs result in the activation of signalling pathways eventuating in host gene regulatory events that likely have broadly cytoprotective effects and with quantitative or qualitatively increased stimulation (Bienenstock et al. 2013) including immune activation, antigen presentation and expression of antimicrobial factors (Lebeer et al. 2010; Wells et al. 2011; Bron et al. 2012a).

The TLRs are a family of single-pass transmembrane glycoproteins, which contain 10 members in humans and 13 in mice (Lavelle et al. 2010). TLR1–TLR7 and TLR9 have been characterized to recognize microbial components. In signalling pathways via TLRs, a common adaptor, MyD88, was first characterized as an essential component for the activation of innate immunity (Dunzendorfer et al. 2004; Takeda and Akira 2004). MyD88 is essential for the induction of inflammatory cytokines triggered by all TLRs through NF-kB or MAP Kinase pathways (Takeda and Akira 2004). TLRs stimulation by probiotics has been widely studied in vivo and in vitro with different types of immune cells. The intensity of stimulation appears to be strain specific. Lact. casei CRL431 administrated to mice for 2, 5 or 7 days induced a significant increase in the number of TLR-2+ cells in the lamina propria of small intestine, with the enhancement being greater for 7 days postadministration. The effect in the number of TLR-2+ cells in Peyer's patches was enhanced only after 5 and 7 days postadministration (Maldonado and Perdigon 2006). Lactobacillus paracasei ssp. paracasei DC412 exhibited strong immunoregulatory activity and interacted strongly with gut-associated lymphoid tissue (GALT) of BALB⁄c inbred mice or Fisher-344 inbred rats through stimulation of TLR2⁄TLR4-mediated signalling events leading to secretion of a certain profile of cytokines namely, IFN-γ, TNF-α, IL-6 and IL-10 (Kourelis et al. 2010). TLR-2 recognizes a variety of microbial components such as lipoproteins/lipopeptides from various pathogens, PGs and LTA from Gram-positive bacteria (Dunzendorfer et al. 2004). TLR2 receptors mainly recognize the PG which is the principal component of the Gram (+) bacteria such as Lactobacillus genus and the ligands bound TLR2 increase the signals to produce cytokines, but also to strengthen the epithelial barrier (Abreu et al. 2005). TLR4 recognizes the LPS present in the cell wall of the Gram (−) bacteria. Upon activation, it initiates an innate immune response leading to the induction of pro-inflammatory mediators, the increase in TLR2 expression and the reduction in its own expression, which leads to the recruitment of inflammatory cells and the initiation of the appropriate responses in the spleen (Weiss et al. 2004). Flagellated bacteria like Salmonella can interact with TLR5 to induce activation of pro-inflammatory gene programmes for host protection (Fournier et al. 2009).

The immunostimulating effect of probiotic lactobacilli can lead to a different pattern of modulation of TLRs as they are lived or dead. For example, live Lact. casei Zhang (LcZ) promotes TLR2 mRNA transcription, whereas heat-killed LcZ enhances transcription of TLR2, TLR3, TLR4 and TLR9 in the murine macrophage cell line RAW264·7 (Wang et al. 2013). Using the human embryonic kidney NF-κB reporter cells expressing TLR-2/6 exposed to purified WTAs and/or the teichoic acid (TA) mutants from Lact. plantarum WCFS1, it was found that WTA is not directly involved in TLR-2/6 signalling, but attenuates this signalling in a backbone-independent manner, likely by affecting the release or exposure of immunomodulatory compounds such as LTA (Bron et al. 2012b), highlighting a shielding effect on PRRs reported elsewhere after activation by WTAs and polysaccharides (Remus et al. 2012).

The reason of strain specificity of probiotics could be laid in the chemical structure variation of MAMPs in terms of polymer composition, length and substitutions. Exemplary to this notion are the studies in several lactobacilli that have targeted the role of D-alanylation of LTA in the immunogenicity of these MAMPs. Loss of D-alanylation of LTA in Lact. plantarum by mutation on dlt operon decreases the capacity of the molecule to elicit pro-inflammatory responses in a TLR2-dependent manner (Grangette et al. 2005). In a mouse model of colitis, the dlt mutant was significantly more protective than its wild-type counterpart (Grangette et al. 2005). Moreover, the species-specific anti-inflammatory effects could be assigned to a particular, NOD-2 binding, PG-associated muropeptide that is released into its environment by protective Lactobacillus salivarius Ls33 but not by the nonprotective Lact. acidophilus NCFM strain (Macho-Fernandez et al. 2011). In addition, it has been shown that variations in the chemical modification (acetylation or pyruvylation) of the conserved PG polymer backbones may contribute to strain- or species-specific immunomodulatory capacities (Kleerebezem et al. 2010).

Effects on negative regulators of TLRs signalling pathways

Although strong pro-inflammatory responses after TLRs stimulation may be beneficial, TLR signalling needs to be fine-tuned to achieve an effective response against dangerous exogenous and endogenous factors, limiting a pathological reaction and restoring the immune balance. Therefore, several mechanisms have evolved which negatively regulate TLR-induced cellular responses at multiple levels of the signalling cascade (Gomariz et al. 2010). These mechanisms act at different levels: as extracellular regulators (soluble TLR2 and TLR4), as transmembrane protein regulators (RP105, ST2L, single immunoglobulin interleukin-1-related receptor (SIGGIR), TNF-related apoptosis-inducing ligand receptor (TRAILR)), as negative regulators of adapter molecules (soluble MyD88 (MyD88s), sterile α and heat-armadillo motifs (SARM), suppressor of cytokine signalling 1 (SOCS1)), as factors affecting effector proteins (interleukin-1 receptor-associated kinase M (IRAK-M), IRAK2, TNF receptor-associated factor 4 (TRAF4), toll-interacting protein (TOLLIP), A20, β-arrestins 1 and 2, LIND, FLN29, CYLD, SHIP-2) and finally as molecules affecting transcription factors (Pin-2, phosphatidylinositol 3-kinase (PI3K), ATF-3, Bcl3) (Liew et al. 2006). There are few reports highlighting the effects of probiotic lactobacilli on negative regulators of TLRs. The pretreatment of Lact. plantarum genomic DNA inhibited the phosphorylation of MAPKs and NF-kB, and also inhibited LPS-induced TNF-α production in response to subsequent LPS stimulation (Kim et al. 2012). Lactobacillus plantarum genomic DNA-mediated inhibition of signalling pathway and TNF-α was accompanied by the suppression of TLR2, TLR4 and TLR9 and the induction of IRAK M, a negative regulator of TLR (Kim et al. 2012). Lactobacillus jensenii TL2937, a strain with a high capacity to activate TLR2, was also the strain with the highest capacity to down-regulate IL-6 and IL-8 production by porcine intestinal epitheliocyte cell line (PIE cells) in challenge with enterotoxigenic Escherichia coli (ETEC) and LPS probably by inhibiting NF-κB and MAPK signalling pathways (Shimazu et al. 2012). Moreover, it was found that negative TLRs regulator MKP-1, A20 and Bcl-3 mRNA expression was up-regulated in PIE cells stimulated with Lact. jensenii TL2937 consequently limiting a pathological reaction (Shimazu et al. 2012). Some probiotics activate anti-inflammatory and regulatory immune effects in the settings of enteric infections and mucosal inflammation. Lactobacillus paracasei CNCM I-4034 and its supernatant dramatically reduce the production of IL-6, IL-8, IL-12p70 and TNF-α in human intestinal DCs challenged with Salmonella typhi (Bermudez-Brito et al. 2012). These authors demonstrated that Lact. paracasei CNCM I-4034 activates the expression of TLR2 in DCs, up-regulates the expression of TOLLIP and promotes the stimulation of TGF-β2, whereas the supernatant of the probiotic increases the secretion of TGF-β1, highlighting the importance of PRRs for probiotic actions (Bermudez-Brito et al. 2012). In another study involving Lact. jensenii TL2937 and swine DC CD172a+, the expression of A20 and TGF-β was not abolished by treating with anti-TLR2 antibodies, suggesting that other PRRs, in addition to TLR2, may be involved in the anti-inflammatory effect of Lact. jensenii TL2937 on CD172a+ APCs (Villena et al. 2012).

Effects on villi structure, mucin and antimicrobial peptide production

The structure of intestinal villi, the number of goblet cells involved in antibacterial production and the incidence of mucin-producing cells are of importance when looking for the health status of intestine. In a study performed to evaluate the impact of probiotic fermented milk with Lact. casei DN-114-001 (108 CFU ml−1) in nonsevere protein-energy-malnutrition mice model, all the test groups showed similar values for goblet cells without significant differences compared with both control groups (malnourished and well-nourished) (Galdeano et al. 2011). The intestinal villi of malnourished control group were short and their numbers were lower than in the well-nourished and Lact. casei group (Galdeano et al. 2011).

Goblet cells synthesize and release mucins, which are highly glycosylated proteins. Mucins are either secreted or membrane bound, and form a gel layer which acts as a protective barrier over the epithelial cells to protect from the harsh lumen environment (McClemens 2011). Lactobacillus crispatus K-11 increased mucin 13 and defensin alpha genes expression in Peyer's patches by twofold compared with control, ensuring constant protection against the attack of digestive fluid, micro-organisms, pollutants and toxins (Tobita et al. 2010). Moreover, the pili-encoding operon spaABC of Lact. rhamnosus GG (LGG) coding for the SpaC protein has been shown to bind to mucus, providing an explanation for the longer persistence of this strain in the human intestine compared with a closely related Lact. rhamnosus strain that lacks pili (Kankainen et al. 2009). The spa operon-encoded pili have also been proposed to modulate IL-8 induction in Caco-2 cells (Lebeer et al. 2012).

In the intestinal fluid, there are two main types of antimicrobial peptides: cathelicidins and defensins. The former is constitutively expressed by IECs while defensins are expressed primarily by Paneth cells (α-defensin) and IECs (β-defensin) (Wehkamp et al. 2004; Kelsall 2008). The effect of probiotic lactobacilli on cathelicidin production was not investigated up to date, may be because of its permanent expression. In the investigation of Akbari et al. (2008), it was found that a probiotic mixture had no effect on cathelicidin gene expression in chicken tonsils after 5 days of feeding (Akbari et al. 2008). Conversely, in vitro studies have shown that β-defensins expression or secretion was significantly up-regulated in Caco-2 cells upon stimulation by several lactobacilli species and VSL#3 (Schlee et al. 2008). Additionally, it was demonstrated that flagellin is a major stimulatory factor of defensin expression (Schlee et al. 2007) and defensin secretion required MAP Kinases, ERK ½, p38 and JNK pathways in vitro (Wehkamp et al. 2004; Schlee et al. 2008).

Systemic immune system

  1. Top of page
  2. Summary
  3. Introduction
  4. Mucosal immune system
  5. Systemic immune system
  6. Effect of probiotic lactobacilli in challenge with pathogens
  7. Use of lactobacilli as a delivery vehicle for antigens in immunization protocols
  8. Conclusion
  9. Acknowledgements
  10. Conflict of Interest
  11. References

The systemic response of immune system encompasses cytokine and immunoglobulins produced in serum, blood lymphocyte, monocyte and macrophage responses and spleen lymphocyte stimulation. It is not confined to the initial infection site, but works throughout the body. Systemic responses can result from sampling of microbial antigens by DCs in intestinal lumen (usually under epithelial M cells). DCs can transport antigens to local lymph nodes, present antigens to naive immune cells and activate disparate effector responses from B, T helper (Th) and Treg cells, which will further initiate a release of a distinct panel of cytokines that are capable of delivering activating and inhibitory feedback signals to effector immune cells (Hord 2008). The following sections briefly describe interactions between probiotic lactobacilli and parts of systemic immune system above cited with suitable examples.

Effects on cytokines produced by T-lymphocyte subsets

Cytokines are produced by different types of immune cells, mainly T-lymphocyte subsets (Fig. 1) and could be classified into three main groups viz Th1 cytokines (TNF, INF-γ, IL12, IL2, etc.), Th2 cytokines (IL4, IL5, IL6, IL13, etc.) and regulatory cytokines (IL10, TGF-β) (Delcenserie et al. 2008). Accumulating evidence has indicated that probiotic strains have the ability to prevent or attenuate allergic diseases by altering Th1 responses (Chuang et al. 2007). Moreover, certain probiotic strains may promote the production of cytokines, including IFNγ, IL12, IL2, TNFα and IL6 from Th1/Th17 cells (Boirivant and Strober 2007), while some of other probiotic strains may promote the production of regulatory cytokines, including IL10 and TGF-β from Tregs (Belkaid and Tarbell 2009; Zhang et al. 2010). It was recently demonstrated that Lact. plantarum, Lact. salivarius and Lactococcus lactis attenuate Th2 response and increase the production of regulatory cytokines in healthy mice in a strain-dependent manner (Smelt et al. 2012). Live and heat-killed lactobacilli affect cytokines production. In a study conducted by Lee et al. (2011), it was found that the levels of INF-γ were strain-dependent, and Lactobacillus gasseri strains and Lact. plantarum strains induced more than the positive control LGG. The production of Th1 cell-specific cytokines (IFN-γ and IL2) increased, while Th2-specific cytokines (IL4 and IL6) decreased in the supernatant of cultured splenocytes, collected from mice fed with probiotic Dahi compared with the other groups (Shalini et al. 2010). The heat-killed bacteria (containing no bacterial metabolites) induced proliferation as well in a strain-dependent manner, suggesting that the surface properties of some of lactobacilli elicit an immune response, as reflected by the release of INF-γ and lymphocyte proliferation (Lee et al. 2011). In a similar study, live and heat-killed LcZ administrated via oral route to BALB/c mice showed a significant effect on sera level of INF-γ, IL12 compared with control group. However, TNF-α was significantly reduced and no change was observed on IL1α level (Ya et al. 2008). Therefore, the immunoregulatory effects of LcZ was ascribed to a skew of the Th1/Th2 balance in favour of Th1-mediated immunity as it has been shown with Lactobacillus brevis SBC8803 (Segawa et al. 2008). Heat-treated Lact. crispatus K-11 did not influence the Th1/Th2 balance as illustrated by no change in the IFN-γ+CD4+ and IL-4+CD4+ cells in the normal C#H/HeN mice (Tobita et al. 2010). However, it reduced allergic symptoms by shifting the Th1/Th2 balance from Th2 dominant state to a Th1 dominant state in type I allergic model mice (Tobita et al. 2009). The metabolites, especially the bioactive peptides released during fermentation by LAB could contribute to the known immunomodulatory effects of probiotic bacteria. The peptidic fraction released in milk fermented by Lactobacillus helveticus R389 was evaluated for its immunomodulatory properties in a BALB/c murine model after E. coli O157:H7 infection. Cytokine profiling revealed stimulation of a Th2 response in mice fed the peptidic fraction, whereas infected controls demonstrated a proinflammatory Th1 response (LeBlanc et al. 2004). The use of Lact. casei Shirota was also able to enhance NK cell activity and this activity was correlated with an IL12 production, another cytokine implicated in NK cells activity (Takeda et al. 2006). This study suggests that probiotics may play a major role in boosting the immunosurveillance of NK cells, thus helping to prevent the development of malignant tumours.

To decipher the mechanism by which probiotics influence the cytokine production, the WTA and LTA of Lact. casei Shirota and Lact. plantarum ATCC 14917 have been shown in vitro to skew IL10/IL12 ratios in macrophages towards IL10 via a TLR2–extracellular signal-regulated kinase (ERK) signalling axis (Kaji et al. 2010). It has been demonstrated also that the absence of Lact. plantarum TA D-alanylation affects its pro- and anti-inflammatory immunomodulatory capacity in murine host cells in vitro. In murine DCs, the absence of D-alanylation substitution did not affect the Lact. plantarum-induced pro-inflammatory TNFα response, whereas a trend towards an increased IL10 response and IL10/TNFα ratio was observed after co-incubation with D-alanylation negative derivative (dltX-D) as compared with wild type, suggesting that the immunomodulatory capacity is reflected by the composition of TA (Smelt et al. 2013). Moreover, in vivo transcriptome studies investigating adult human duodenal responses have suggested that BCL-9, ERK3, jun proto-oncogene (JUN) and poly(ADP-ribose) polymerase (PARP)14 are involved in signalling events induced by LGG consumption, and that signalling via an IFN–signal transducer and activator of transcription (STAT) 4 axis stimulates the production of mainly Th1-type cytokines (van Baarlen et al. 2011).

Effects on immunoglobulin titres

Immunoglobulin (Ig) production occurs during the adaptive immune response. Several studies confirmed that probiotic induced changes in Ig level in serum. IgG is predominately involved in the secondary antibody response, which occurs later following antigen recognition. IgG level in serum of mice fed with LcZ was significantly increased as compared with control group. The mechanism of action is still unknown but it is conceivable that some biological activate peptides released from LcZ may involve in triggering secondary antibodies responses (Ya et al. 2008). Similarly, oral inoculation of recombinant Lact. casei 525 into specific-pathogen-free BALB/c mice resulted in significantly high levels of IgG in serum with prominent IgG1 titres as well as IgG2a and IgG2b titres indicating the use of recombinant Lact. casei 525 for future vaccine development against E. coli ETEC C83919 (Liu et al. 2009). The continuous administration of multistrain probiotics Lact. rhamnosus NBM-01-07-001, Lact. acidophilus NBM-01-07-002, Lact. plantarum NBM-01-07-003, Bifidobacterium longum NBM-01-07-004 and Enterococcus faecium NBM-01-05-001 for 28 days to BALB/c mice orally, showed the same rise effect on the total serum IgA and IgG antibody levels compared with control (Ho et al. 2011). Many other investigators observed that the total serum IgG level increased after administration of lactobacilli to Balb/c mice (Tsai et al. 2008; Ya et al. 2008). The effect on subtypes was also noticed by few authors. In this regard, after oral administration, Lactobacillus johnsonii NCC 533 skewed systemic IgG isotypes towards a greater proportion of IgG1, an isotype that is associated with IL4 induction of B cells and a Th2 predominant immune response. In contrast, Lact. paracasei NCC 2461 induced a greater proportion of IgG2a, which results from IFN-γ stimulation of B cells, and is associated with a Th1 predominant immune response (Ibnou-Zekri et al. 2003). Treatment with orally administered stationary phase Lact. casei ATCC 393 or Lactobacillus murinus CNRZ increased the IgG1/IgG2a ratio without altering the overall amount of systemic IgG. This increased IgG1 response may reflect a higher CD4+ Th2 cell activity in these mice (Maassen et al. 2003). In allergic condition induced by intraperitoneal injection of ovalbumin, mice fed with Lact. helveticus fermented milk and its cell-free supernatant (CFS) showed a less production of total IgE and ovalbumin-specific IgE in the serum, underscoring that the metabolites produced in CFS could be responsible for the observed effect (Kapila et al. 2008).

Effects on lymphocyte proliferation and Peripheral Blood Mononuclear cell (PBMC)

Lymphocyte proliferation is usually determined by using the 3-(4, 5 dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) cell proliferation assay. It is a colorimetric assay that measures mitochondrial function, which serves as an index of live, metabolically active cells. In a recent study, splenic lymphocytes were treated for 72 h with different lactobacilli strains. Some of them have no effect, while others promoted lymphocyte proliferation with Lactobacillus fermentum LA12, and Lact. plantarum CJMA1, CJLP56, CJLP133, CJLP243, CJNR26 and BJ53 being more effective than the LPS positive control, illustrating their potential as immunomodulators (Lee et al. 2011). Probiotic can also show no stimulation in lymphocyte proliferation, but it remains strain specific. The proliferation of lymphocyte from mice spleen in response to standard mitogens (LPS and ConA) in vivo after 15, 18 and 25 days of daily administration of Lact. plantarum showed no variation in a spleen response to LPS, but slight increase in the proliferative response to ConA only after 18 days, followed by a reduction as in control 25 day of daily feeding (Bujalance et al. 2007). This result showed that the stimulation with Lact. plantarum was not continuous throughout the 25 days of feeding. To understand how lactobacilli could induce lymphocyte proliferation, the effect of the structure of TA was investigated. It was observed that in the absence D-alanylation substitution in TA, the generation of Treg cells decreased significantly suggesting that this compound is also necessary for stimulation and proliferation of T cells subset in healthy mice (Smelt et al. 2013).

The PBMC are generally used in probiotic studies to identify probable immunomodulatory characteristics of lactobacilli to obtain additional information on their potential probiotic effects. Drouault-Holowacz et al. (2006) have tested the capacity of lactibiane tolerance strains (a mixture containing 4 × 109 CFU g−1 of viable lyophilized LAB consisting of 12·5% Bifidobacterium lactis LA 303, 12·5% Lact. acidophilus LA 201, 50% Lact. plantarum LA 301 and 25% of Lactobacillus salivarius LA302) to induce the secretion of IL10 and IL12 after 24 h of culture with human PBMC. Individually, Lact. salivarius LA302 and Bif. lactis LA303 strongly induced IL10 more than a mixture, and they both lowly stimulated the production of pro-inflammatory IL12 (Drouault-Holowacz et al. 2006). The variation in immunomodulatory effects between species is even larger than the variation between the strains of the same species. After 1 and 4 days of co-culture of human PBMC with different species of Lact. acidophilus and Lact. plantarum, all tested strains induced differently the production of IL1β, IL10, IFN-γ and TNF-α with Lact. plantarum exhibiting higher induction capacity of IFN-γ, IL12 and TNF-α compared with Lact. acidophilus strains (Vissers et al. 2010). Similarly, live cells of probiotic lactobacilli (Lact. casei Shirota, LGG, Lact. plantarum NCIMB 8826 and Lactobacillus reuteri NCIMB 11951) after individual incubation with human PBMC for 24 h showed an increased production of IL1β, IL6, IL10, TNF-α, granulocyte-macrophage colony-stimulating factor and macrophage inflammatory protein 1α to different extents, but had no effect on the production of IL2, IL4, IL5 or TNF-β (Dong et al. 2012). The reason behind the strain specificity could lay on soluble factors produced by probiotic that could modulate cytokine production by PBMC. To exemplify that, PBMC treated with Lact. reuteri CRL1098 soluble factors (Lr-S) showed a reduced production of TNF-α (Mechoud et al. 2012). It is important to note that the use of PBMC is an artificial screening tool, as under normal healthy conditions, intestinal bacteria do not enter the circulation, and thus cannot communicate directly with such cells because of the ‘firewall’ effect guaranteed by the MLN (Macpherson and Smith 2006).

Effects on macrophage function and leucocyte count

The activation of peritoneal macrophages is one parameter that indicates the stimulation of the systemic immune system but the mechanism used by probiotic strains is still unclear. Several authors observed the increase in the phagocytic activity of peritoneal macrophage after 2, 5 or 8 days of feeding with probiotics cultures (Kapila et al. 2007, 2012; Rajpal and Kansal 2009), even after 60 days (Kapila et al. 2013). Same effects were perceived with the probiotic Dahi culture namely DI (containing Lact. acidophilus, Lact. casei and Lc. lactis ssp. lactis biovar diacetylactis) and DII (containing Lact. casei mixed Dahi culture BD4) regarding the phagocytic activity as well as the increase in lysosomal enzymes activity of peritoneal macrophages (Shalini et al. 2010). In another study, undernourished mice, sacrificed after feeding with the fermented milk containing yoghurt starter cultures and probiotic Lact. casei DN-114-001 (108 CFU ml−1), presented the increase in phagocytic activity of macrophages isolated from peritoneum and spleen (Galdeano et al. 2011).

Leucocytes in blood primarily consist of neutrophils, lymphocytes and monocytes. Differential white blood cell count is an important criterion in detection of infection with viruses and/or bacteria. Few works are showing the effect of probiotic on leucocyte count either differential or total. As they have the Generally Recognized As Safe (GRAS) status, probiotic strains usually do not induce significant changes in leucocyte count in healthy animals compared with control groups. Bujalance et al. (2007), after feeding mice through intragastric route for 25 days continuously with Lact. plantarum at a dose of about 109 viable bacteria in 100 μl of skimmed milk, did not find a difference in total leucocyte count when comparing with control mice who received skimmed milk only. Similarly, no statistical difference was observed in a count of lymphocytes, neutrophils and monocytes after feeding of Lact. acidophilus 381-IL-28 (Luyai 2004).

Another evidence of the systemic influence of the microbiota on systemic immune responses was recently provided. Despite by being contained by mucosal immunity, gut probiotics can impact responses at distal sites. Interestingly, a recent study demonstrated that PG from radio-labelled E. coli could be found in the serum and improved killing of Streptococcus pneumoniae and Staphylococcus aureus by bone-marrow-derived neutrophils in an NOD1-dependent manner (Clarke et al. 2010). Importantly, detection of MAMPs is not limited to the intestinal mucosa but also has been shown to occur in the bone marrow where signalling can alter hematopoiesis (Molloy et al. 2012).

Effect of probiotic lactobacilli in challenge with pathogens

  1. Top of page
  2. Summary
  3. Introduction
  4. Mucosal immune system
  5. Systemic immune system
  6. Effect of probiotic lactobacilli in challenge with pathogens
  7. Use of lactobacilli as a delivery vehicle for antigens in immunization protocols
  8. Conclusion
  9. Acknowledgements
  10. Conflict of Interest
  11. References

Challenge studies are useful to assess the effectiveness of probiotic cultures. Scientific evidences are showing the ability of probiotics to prevent or protect and cure several pathological conditions with pathogenic bacteria. Results are quite variable depending upon the specie and the concentration of pathogenic/probiotic strain, the pre- and postinfection time period, the age and health status of animals used and many more factors. Different pathogens have been used in animal models for challenge studies with probiotics. The protective effect of Lact. casei DN-114-001 on translocation of Salmonella typhimurium to spleen, liver and large intestine was prominent in mice and illustrated by a significant decrease in Salmonella counts (Galdeano et al. 2011). In a similar study, the level of IgA and IgG in serum and S-IgA was increased only in co-infection group of the probiotic Lactobacillus sp. Dad13 and Salm. typhimurium (Kusumawati et al. 2006). The administration of Lact. casei in the form of fermented milk and nonfermented milk to mice infected with Shigella dysenteria reduced the colonization in the intestine, liver and spleen and increased the concentration of S-IgA in the intestinal fluid of probiotic groups (Kapila et al. 2007). In the work conducted by De Moreno de LeBlanc et al. (2010) investigating the preventive and therapeutic effect of the probiotic Lact. casei CRL 431, results obtained show that 7 days prefeeding Lact. casei CRL 431 decreased the severity of the infection with Salmonella enteritidis serovar Typhimurium, demonstrating that the continuous administration (even after infection) had the best effect. This continuous administration diminished the counts of the pathogen in the intestine as well as its spread outside this organ (De Moreno de LeBlanc et al. 2010). The oral administration of Lact. casei CRL 431 induced variations in the cytokine profile and in the TLRs expression, before and also after the challenge with Salm. typhimurium in mice. The probiotic administration to healthy mice increased the expression of TLR2, TLR4 and TLR9 and improved the production and secretion of TNF-α, IFN-γ and IL10 in the inductor sites of the gut immune response (Peyer's patches) (Castillo et al. 2011). Same authors mentioned that Lact. casei CRL 431 administration increased TLR5 expression after Salmonella infection in groups that received the probiotic strain for 7 days postchallenge (Castillo et al. 2011). The mechanism of protection by probiotic against pathogenic bacteria is quite diverse. Certain probiotic strains (Lact. plantarum, Bifidobacterium infantis) have the capacity to enhance gut barrier function through altering gene expression and distribution of occludin, ZO-1, ZO-2 and different claudin isoforms, therefore strengthening the junction between epithelial cells in the interface between the host and the environment (Ewaschuk et al. 2008; Miyauchi et al. 2012; Mathias et al. 2013; Pruteanu and Shanahan 2013). Probiotics are also known to reduce antibiotic-associated diarrhoea (AAD) and Clostridium difficile-associated diarrhoea (CDAD) risk in a strain-specific manner (Allen et al. 2013; Ouwehand et al. 2014). The Gram-positive (VSL#3) and Gram-negative EcN (E. coli Nissle) probiotic culture could differentially protect against Salmonella dublin infection in vitro using HT29 IEC, illustrating the profound differences existing in the composition of the bacterial cell wall (Mathias and Corthésy 2011). EcN as well as debris and cell extracts induced IL8 secretion from IEC, whereas no such effect was observed following incubation with the VSL#3 (Otte and Podolsky 2004). The latter and its soluble protein(s) increased transepithelial resistance (TER), prevented pathogen-induced decrease in TER, and were shown to stabilize tight junctions and to induce expression of mucins in IEC. By different mechanisms, they both diminished S. dublin-induced cell death (Otte and Podolsky 2004). Others probiotics have been reported to induce secretion of S-IgA (Kapila et al. 2007), cytokines and Ig in serum (Kusumawati et al. 2006), secretion of defensins, mucins, heat shock proteins and antimicrobial peptides from epithelial cells (Schlee et al. 2008; Salzman et al. 2010; Gourbeyre et al. 2011), secretion of bacteriocins (Servin 2004), decreased adhesion of pathogens on epithelial cells (Sun et al. 2007) and stimulation of cytokine-producing cells at Peyer's patches (Castillo et al. 2011).

Use of lactobacilli as a delivery vehicle for antigens in immunization protocols

  1. Top of page
  2. Summary
  3. Introduction
  4. Mucosal immune system
  5. Systemic immune system
  6. Effect of probiotic lactobacilli in challenge with pathogens
  7. Use of lactobacilli as a delivery vehicle for antigens in immunization protocols
  8. Conclusion
  9. Acknowledgements
  10. Conflict of Interest
  11. References

Food-grade lactobacilli have been safely consumed for centuries by humans in fermented foods. Thus, they are good candidates to develop oral vectors, constituting attractive alternatives to attenuated pathogens, for antigen delivery strategies in immunization. Mucosal surfaces are the primary interaction sites between an organism and its environment and they thus represent the major portal of entry for pathogens. Mucosal immunization is advantageous over other routes of antigen delivery because it can induce both mucosal and systemic immune responses (del Rio et al. 2008). There have been numerous reports of successful immunization with a variety of lactobacilli strains, showing efficient systemic immune response with less collateral side effects than systemic vaccines. The immunopotential of the recombinant strain of Lact. casei capable of producing Beta-lactoglobulin (BLG), one of the major allergens found in cow's milk, was investigated in cow's milk allergy model (Hazebrouck et al. 2009). Intranasal preadministration of the BLG-producing Lact. casei enhanced BLG-specific IgG2a and IgG1 responses in serum, but did not influence BLG-specific IgE production in sensitized mice (Hazebrouck et al. 2009). Unexpectedly, oral preadministration led to a significant inhibition of BLG-specific IgE production, whereas IgG1 and IgG2a responses were not stimulated in sensitized mice (Hazebrouck et al. 2009). These results indicated that the mode of administration of recombinant LAB might be critical for their immunomodulatory properties. Similarly, oral immunization with Lact. plantarum expressing wild-type OspA (the outer surface protein A of Borrelia burgdorferi involve in Lyme disease) induced primarily IgG2a, a Th1-driven immune response, that could be advantageous for vaccination strategies (del Rio et al. 2008). The recombinant lactobacilli can induce specific humoral (protective) and mucosal antibodies and cellular immune response against protective antigens upon nasal administration. Lactobacillus plantarum strain of human origin (NCIMB8826) expressing the 47-kDa fragment C of tetanus toxin (TTFC) was used to elicit immune response by intranasal delivery using mice model (Grangette et al. 2001). The recombinant strain elicited very high systemic immunoglobulin G (IgG1, IgG2b, and IgG2a) responses in serum which correlated to the antigen dose (Grangette et al. 2001). Moreover, significant TTFC-specific mucosal IgA responses were measured in bronchoalveolar lavage fluids, and antigen-specific T cell responses were detected in cervical lymph nodes, both responses being higher in mice receiving a double dose of bacteria (at a 24-h interval) at each administration (Grangette et al. 2001). Few years later, the same Lact. plantarum NCIMB8826 was engineered to express UreB, a Helicobacter pylori urease subunit and deliver it to the gastrointestinal tract. Intragastric immunization elicited UreB-specific antibodies (Corthesy et al. 2005). Moreover, stomach load of Helicobacter felis reduced significantly after challenge in mice fed with the recombinant Lact. plantarum (Corthesy et al. 2005). This showed a successful induction of partial protection against H. felis. Many other recent studies performed with strains of Lact. casei (Poo et al. 2006; Kajikawa et al. 2007; Lee et al. 2010; Kajikawa 2012; Wen et al. 2012b), Lact. acidophilus (Moeini et al. 2010) and Lact. johnsonii (Scheppler et al. 2002) showed the efficiency of lactobacilli as antigen delivery vehicle. However, comparison of the different vaccine delivery and adjuvant systems is difficult for several reasons that include antigen nature, dose and cellular location of the recombinant (cytoplasmic vs bound to the cell membrane vs bound to the cell wall), intrinsic antigenicity and immunomodulatory properties of the bacterial carrier, mouse strain and immunization protocol.

Conclusion

  1. Top of page
  2. Summary
  3. Introduction
  4. Mucosal immune system
  5. Systemic immune system
  6. Effect of probiotic lactobacilli in challenge with pathogens
  7. Use of lactobacilli as a delivery vehicle for antigens in immunization protocols
  8. Conclusion
  9. Acknowledgements
  10. Conflict of Interest
  11. References

In summary, although specific in vivo or in vitro immunomodulatory properties can be attributed to specific bacteria, probiotic-induced immunomodulation is a complex interplay of different host-microbe interactions. The task remains difficult due to the specificity of their stimulation that could be attributed to the varying composition of MAMPs involved in cross-talk with host immune system, and the plethora of active metabolites produced by probiotic lactobacilli. The puzzle of the precise mechanism is not yet completed but it seems likely that the intestinal epithelial cells, macrophages, dendritic cells (from lamina propria and circulation) and lymphocytes are all differently affected in some way by probiotic strains or metabolites, making the statement of a general mechanism arduous. On the other hand, the use of probiotic lactobacilli strains as delivery vehicle for antigen is an alternative strategy to successfully overcome the disadvantage of inactivated vaccines. The variety of antigens evaluated, the progress made so far in the immune parameters involved in the protective effect of recombinant vaccines and the safety considerations of their application in humans suggest that the use of recombinant lactobacilli as an antigen vehicle represents a tangible option to control infections. Future directions in immunomodulatory studies of lactobacilli should continue to elucidate the effects of single probiotic strain to explore all currently unknown and unappreciated pathways in the host and to complete what is known. The challenge over the next few years will be to develop novel experimental approaches allowing the exploration of the complexes and constantly evolving interactions between probiotic lactobacilli and their hosts.

Acknowledgements

  1. Top of page
  2. Summary
  3. Introduction
  4. Mucosal immune system
  5. Systemic immune system
  6. Effect of probiotic lactobacilli in challenge with pathogens
  7. Use of lactobacilli as a delivery vehicle for antigens in immunization protocols
  8. Conclusion
  9. Acknowledgements
  10. Conflict of Interest
  11. References

The authors are thankful to the Director of National Dairy Research Institute (NDRI, Karnal) for providing facilities. T.S. Kemgang thanks the Ministry of External Affairs (Government of India) and the African Union for the award of Doctoral Fellowship.

References

  1. Top of page
  2. Summary
  3. Introduction
  4. Mucosal immune system
  5. Systemic immune system
  6. Effect of probiotic lactobacilli in challenge with pathogens
  7. Use of lactobacilli as a delivery vehicle for antigens in immunization protocols
  8. Conclusion
  9. Acknowledgements
  10. Conflict of Interest
  11. References
  • Abreu, M.T., Fukata, M. and Arditi, M. (2005) TLR signaling in the gut in health and disease. J Immunol 174, 44534460.
  • Akbari, M.R., Haghighi, H.R., Chambers, J.R., Brisbin, J., Read, L.R. and Shayan-Sharif, S. (2008) Expression of antimicrobial peptides in cecal tonsils of chickens treated with probiotics and infected with Salmonella enterica Serovar Typhimurium. Clin Vaccine Immunol 15, 16891693.
  • Allen, S.J., Wareham, K., Wang, D., Bradley, C., Hutchings, H., Harris, W., Dhar, A., Brown, H. et al. (2013) Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 382, 12491257.
  • Ashraf, R. and Shah, N.P. (2014) Immune system stimulation by probiotic microorganisms. Crit Rev Food Sci Nutr 54, 938956. doi:10.1080/10408398.2011.619671.
  • van Baarlen, P., Troost, F.J., van Hemert, S., van der Meer, C., de Vos, W.M., de Groot, P.J., Hooiveld, G.J., Brummer, R.J. et al. (2009) Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc Natl Acad Sci USA 106, 23712376.
  • van Baarlen, P., Troost, F., van der Meer, C., Hooiveld, G., Boekschoten, M., Brummer, R.J. and Kleerebezem, M. (2011) Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proc Natl Acad Sci USA 108, 45624569.
  • Belkaid, Y. and Tarbell, K. (2009) Regulatory T cells in the control of host-microorganism interactions. Annu Rev Immunol 27, 551589.
  • Bermudez-Brito, M., Muñoz-Quezada, S., Gomez-Llorente, C., Matencio, E., Bernal, M.J., Romero, F. and Gil, A. (2012) Human intestinal dendritic cells decrease cytokine release against Salmonella infection in the presence of Lactobacillus paracasei upon TLR Activation. PLoS ONE 7, e43197.
  • Bienenstock, J., Gibson, G., Klaenhammer, T.R., Walker, A.W. and Neish, A.S. (2013) New insights into probiotic mechanisms A harvest from functional and metagenomic studies. Gut Microbes 4, 17.
  • Boirivant, M. and Strober, W. (2007) The mechanism of action of probiotics. Curr Opin Gastroenterol 23, 679692.
  • Bron, P.A., van Baarlen, P. and Kleerebezem, M. (2012a) Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol 10, 6678.
  • Bron, P.A., Tomita, S., van Swam, I.I., Remus, D.M., Meijerink, M., Wels, M., Okada, S., Wells, J.M. et al. (2012b) Lactobacillus plantarum possesses the capability for wall teichoic acid backbone alditol switching. Microb Cell Fact 11, 123.
  • Bujalance, C., Moreno, E., Jimenez-Valera, M. and Ruiz-Bravo, A. (2007) A probiotic strain of Lactobacillus plantarum stimulates lymphocyte responses in immunologically intact and immunocompromised mice. Int J Food Microbiol 113, 2834.
  • Castillo, N.A., Perdigon, G., Moreno, De. and de Leblanc, A. (2011) Oral administration of a probiotic Lactobacillus modulates cytokine production and TLR expression improving the immune response against Salmonella enterica serovar Typhimurium infection in mice. BMC Microbiol 11, 177189.
  • Chuang, L., Wu, K.G., Pai, C., Hsieh, P.S., Tsai, J.J., Yen, J.H. and Lin, M.Y. (2007) Heat-killed cells of lactobacilli skew the immune response toward T helper 1 polarization in mouse splenocytes and dendritic cell treated T cells. J Agric Food Chem 55, 1108011086.
  • Clarke, T.B., Davis, K.M., Lysenko, E.S., Zhou, A.Y., Yu, Y. and Weiser, J.N. (2010) Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med 16, 228231.
  • Corthesy, B. (2013) Multi-faceted functions of secretory IgA at mucosal surfaces. Front Immunol 4, 111.
  • Corthesy, B., Boris, S., Isler, P., Grangette, C. and Mercenier, A. (2005) Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis. J Infect Dis 192, 14411449.
  • Cummings, J.H., Antoine, J.M., Azpiroz, F., Bourdet-Sicard, R., Brandtzaeg, P., Calder, P.C., Gibson, G.R., Guarner, F. et al. (2004) PASSCLAIM–gut health and immunity. Eur J Nutr 43, II118II173.
  • De Moreno de LeBlanc, A., Chaves, S., Carmuega, E., Weill, R., Antoine, J. and Perdigon, G. (2008) Effect of long-term continuous consumption of fermented milk containing probiotic bacteria on mucosal immunity and the activity of peritoneal macrophages. Immunobiology 213, 97108.
  • De Moreno de LeBlanc, A., Castillo, A.N. and Perdigon, G. (2010) Anti-infective mechanisms induced by a probiotic Lactobacillus strain against Salmonella enterica serovar Typhimurium infection. Int J Food Microbiol 138, 223231.
  • Delcenserie, V., Martel, D., Lamoureux, M., Amiot, J., Boutin, Y. and Roy, D. (2008) Immunomodulatory effects of probiotics in the intestinal tract. Curr Issues Mol Biol 10, 3754.
  • Delves, P.J. and Roitt, I.M. (2000) The immune system. First of two parts. N Engl J Med 343, 3749.
  • Dong, H., Rowland, I. and Yaqoob, P. (2012) Comparative effects of six probiotic strains on immune function in vitro. Br J Nutr 108, 459470.
  • Drouault-Holowacz, S., Foligne, B., Dennin, V., Goudercourt, D., Terpend, K., Burckel, A. and Pot, B. (2006) Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolerance: in vitro and in vivo considerations. Clin Nutr 25, 9941003.
  • Dunzendorfer, S., Lee, H.K., Soldau, K. and Tobias, P.S. (2004) TLR4 is the signaling but not the lipopolysaccharide uptake receptor. J Immunol 22, 3354.
  • Evrard, B., Coudeyras, S., Dosgilbert, A., Charbonnel, N., Alame, J. and Tridon, A. (2011) Dose-dependent immunomodulation of human dendritic cells by the probiotic Lactobacillus rhamnosus Lcr35. PLoS ONE 6, e18735.
  • Ewaschuk, J.B., Diaz, H., Meddings, L., Diederichs, B., Dmytrash, A. and Backer, J. (2008) Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol 295, G1025G1034.
  • FAO/WHO (2001) Regulatory and clinical aspects of dairy probiotics. FAO and WHO expert consultation report.
  • Fink, L.N., Zeuthen, L.H., Christensen, H.R., Morandi, B., Frøkiær, H. and Ferlazzo, G. (2007) Distinct gut-derived lactic acid bacteria elicit divergent dendritic cell-mediated NK cell responses. Int Immunol 19, 13191327.
  • Fournier, B., Williams, I.R., Gewirtz, A.T. and Neish, A.S. (2009) Toll-like receptor 5-dependent regulation of inflammation in systemic Salmonella enterica Serovar typhimurium infection. Infect Immun 77, 41214129.
  • Galdeano, C.M., LeBlanc, A.M., Viderola, G., Bonet, M.E.B. and Perigón, D. (2007) Proposed Model: mechanisms of immunomodulation induced by probiotic bacteria. Clin Vaccine Immunol 14, 485492.
  • Galdeano, M.C., Núñez, I.N., de Moreno de Le Blanc, A., Carmuega, E., Weill, R. and Perdigón, G. (2011) Impact of a probiotic fermented milk in the gut ecosystem and in the systemic immunity using a non-severe protein-energy-malnutrition model in mice. BMC Gastroenterol 11, 64.
  • Gomariz, R.P., Gutiérrez-Cañas, I., Arranz, A., Carrión, M., Juarranz, Y., Leceta, J. and Martínez, C. (2010) Peptides targeting Toll-Like Receptor signaling pathways for novel immune therapeutics. Curr Pharm Des 16, 10631080.
  • Goodrich, M.E. and McGee, D.W. (1999) Effect of intestinal epithelial cell cytokines on mucosal B-cell IgA secretion: enhancing effect of epithelial derived IL-6 but not TGF beta on IgA B cells. Immunol Lett 67, 1114.
  • Gourbeyre, P., Denery, S. and Bodinier, M. (2011) Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions. J Leukoc Biol 89, 685695.
  • Grangette, C., Muller-Alouf, H., Goudercourt, D., Geoffroy, M.C., Turneer, M. and Mercenier, A. (2001) Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum. Infect Immun 69, 15471553.
  • Grangette, C., Nutten, S., Palumbo, E., Morath, S., Hermann, C., Dewulf, J., Pot, B., Hartung, T. et al. (2005) Enhanced anti-inflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc Natl Acad Sci USA 10, 1032110326.
  • Gupta, V. and Garg, R. (2009) Probiotics. Indian J Med Microbiol 27, 202209.
  • Hazebrouck, S., Przybylski-Nicaise, L., Ah-Leung, S., Adel-Patient, K., Corthier, G., Langella, P. and Wal, J.M. (2009) Influence of the route of administration on immunomodulatory properties of bovine beta-lactoglobulin-producing Lactobacillus casei. Vaccine 27, 58005805.
  • Hemaiswarya, S., Raja, R., Ravikumar, R. and Carvalho, I.S. (2013) Mechanism of action of probiotics. Braz Arch Biol Technol 56, 113119.
  • Ho, C.-Y., Chen, C.-Y., Chen, Y.-C. and Tsai, C.-C. (2011) Effects of multistrain lactic acid bacteria with probiotic properties on enhancements of IgA, IgG levels and anti-Salmonella typhimurium invasion activity. Available at: http://web.hk.edu.tw/~gas/main/download/journal/63/156-173.pdf (accessed 24 November 2013).
  • Hord, M.G. (2008) Eukaryotic-microbiota crosstalk: potential mechanisms for health benefits of prebiotics and probiotics. Annu Rev Nutr 28, 215231.
  • Ibnou-Zekri, N., Blum, S., Schiffrin, E.J. and von der Weid, T. (2003) Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect Immun 71, 428436.
  • Izcue, A., Coombes, J. and Powrie, F. (2009) Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol 27, 313338.
  • Kaji, R., Kiyoshima-Shibata, J., Nagaoka, M., Nanno, M. and Shida, K. (2010) Bacterial teichoic acids reverse predominant IL-12 production induced by certain Lactobacillus strains into predominant IL-10 production via TLR2-dependent ERK activation in macrophages. J Immunol 184, 35053513.
  • Kajikawa, A. (2012) Protection against Salmonella via immunization with recombinant lactic acid bacteria. Nihon Rinsho 70, 12931297.
  • Kajikawa, A., Satoh, E., Leer, R.J., Yamamoto, S. and Igimi, S. (2007) Intragastric immunization with recombinant Lactobacillus casei expressing flagellar antigen confers antibody-independent protective immunity against Salmonella enterica serovar Enteritidis. Vaccine 25, 35993605.
  • Kankainen, M., Paulin, L., Tynkkynen, S., von Ossowski, I., Reunanen, J., Partanen, P., Satokari, R., Vesterlund, S. et al. (2009) Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human mucus binding protein. Proc Natl Acad Sci USA 106, 1719317198.
  • Kapila, S., Sinha, P.R. and Singh, S. (2007) Influence of feeding fermented milk and non-fermented milk containing Lactobacillus casei on immune response in mice. Food Agric Immunol 18, 7582.
  • Kapila, S., Jain, S., Haque, E., Sabikhi, L. and Dang, A.K. (2008) Immunoregulatory response of Lactobacillus helveticus fermented milk in mice. Milchwissenschaft 63, 367369.
  • Kapila, R., Kapila, S., Kapasiya, M., Pandey, D., Dang, A. and Saliganti, V. (2012) Comparative evaluation of oral administration of probiotic Lactobacilli-fermented milks on macrophage function. Probiotics Antimicrob Proteins 4, 173179. doi:10.1007/s12602-012-9107-x.
  • Kapila, R., Sebastian, R., Varma, V., Sharma, R., Kapasiya, M., Salingati, V., Kapila, S. and Dang, A. (2013) Comparison of innate immune activation after prolonged feeding of milk fermented with three species of Lactobacilli. Microbiol Immunol 57, 778784. doi: 10.1111/1348-0421.12092.
  • Kato, L.M., Kawamoto, S., Maruya, M. and Fagarasan, S. (2014) Gut TFH and IgA: key players for regulation of bacterial communities and immune homeostasis. Immunol Cell Biol 92, 4956.
  • Kelsall, B.L. (2008) Innate and adaptive mechanisms to control pathological intestinal inflammation. J Pathol 214, 242259.
  • Kim, C.H., Kim, H.G., Kim, J.Y., Kim, N.R., Jung, B.J., Jeong, J.H. and Chung, D.K. (2012) Probiotic genomic DNA reduces the production of pro-inflammatory cytokine tumor necrosis factor-alpha. FEMS Microbiol Lett 328, 1319.
  • Kleerebezem, M., Hols, P., Bernard, E., Rolain, T., Zhou, M., Siezen, R.J. and Bron, P.A. (2010) The extracellular biology of the lactobacilli. FEMS Microbiol Rev 34, 199230.
  • Koch, S. and Nusrat, A. (2012) The life and death of epithelia during inflammation: lessons learned from the gut. Annu Rev Pathol 7, 3560.
  • Konstantinov, S.R., Smidt, H., de Vos, W.M., Bruijns, S.C., Singh, S.K., Valence, F., Molle, D., Lortal, S. et al. (2008) S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci USA 105, 1947419479.
  • Kourelis, A., Zinonos, I., Kakagianni, M., Christidou, A., Christoglou, N., Yiannaki, E., Testa, T., Kotzamanidis, C. et al. (2010) Validation of the dorsal air pouch model to predict and examine immunostimulatory responses in the gut. J Appl Microbiol 108, 274284.
  • Kusumawati, D.I., Harmayani, E. and Asmara, W. (2006) Effect of Probiotic Lactobacillus sp. Dad13 on humoral immune response of Balb/C Mice infected with Salmonella typhimurium. Indones J Biotechnol 11, 870877.
  • Kwon, H.K., Lee, C.G., So, J.S., Chae, C.S., Hwang, J.S., Sahoo, A., Nam, J.H., Rhee, J.H. et al. (2010) Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci USA 107, 21592164.
  • Lavelle, E.C., Murphy, C., O'Neill, L.A. and Creagh, E.M. (2010) The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis. Mucosal Immunol 3, 1728.
  • Lebeer, S., Jos Vanderleyden, S. and De Keersmaecker, C.J. (2008) Genes and molecules of Lactobacilli Supporting probiotic action. Microbiol Mol Biol Rev 72, 728.
  • Lebeer, S., Vanderleyden, J. and De Keersmaecker, S.C. (2010) Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol 8, 171184.
  • Lebeer, S., Claes, I., Tytgat, H.L., Verhoeven, T.L., Marien, E., von Ossowski, I., Reunanen, J., Palva, A. et al. (2012) Functional analysis of Lactobacillus rhamnosus GG pili in relation to adhesion and immunomodulatory interactions with intestinal epithelial cells. Appl Environ Microbiol 78, 185193.
  • LeBlanc, J., Fliss, I. and Matar, C. (2004) Induction of a humoral immune response following an Escherichia coli O157:H7 infection with an immunomodulatory peptidic fraction derived from Lactobacillus helveticus-fermented milk. Clin Diagn Lab Immunol 11, 11711181.
  • Lee, T.Y., Kim, Y.H., Lee, K.S., Kim, J.K., Lee, I.H., Yang, J.M., Sung, M.H., Park, J.S. et al. (2010) Human papillomavirus type 16 E6-specific antitumor immunity is induced by oral administration of HPV16 E6-expressing Lactobacillus casei in C57BL/6 mice. Cancer Immunol Immunother 59, 17271737.
  • Lee, J., Yun, H.S., Cho, K.W., Oh, S., Kim, S.H., Chun, T., Kim, B. and Whang, K.Y. (2011) Evaluation of probiotic characteristics of newly isolated Lactobacillus spp.: immune modulation and longevity. Int J Food Microbiol 148, 8086.
  • Liew, F., Xu, D., Brint, E.K. and O'Neill, A.J. (2006) Negative regulation of Toll like receptor-mediated immune responses. Nature 5, 446458.
  • Liu, J.K., Hou, X.L., Wei, C.H., Yu, L.Y., He, X.J., Wang, G.H., Lee, J.S. and Kim, C.J. (2009) Induction of immune responses in mice after oral immunization with recombinant Lactobacillus casei strains expressing enterotoxigenic Escherichia coli F41 fimbrial protein. Appl Environ Microbiol 75, 44914497.
  • Luyai, E.A. (2004) Effect of lactic acid bacteria (probiotics) on local and systemic immune responses in cattle. Master Thesis, 78p, Oklahoma State University, Stillwater, OK.
  • Maassen, C.B., Boersma, W.J., van Holten-Neelen, C., Claassen, E. and Laman, J.D. (2003) Growth phase of orally administered Lactobacillus strains differentially affects IgG1/IgG2a ratio for soluble antigens: implications for vaccine development. Vaccine 21, 27512757.
  • Macho-Fernandez, E., Valenti, V., Rockel, C., Hermann, C., Pot, B., Boneca, I.G. and Grangette, C. (2011) Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide. Gut 60, 10501059.
  • Macpherson, J.A. and Smith, K. (2006) Mesenteric lymph nodes at the center of immune anatomy. J Exp Med 203, 497500.
  • Macpherson, A.J., Geuking, M.B. and McCoy, K.D. (2005) Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria. Immunology 115, 153162.
  • Macpherson, A.J., Geuking, M.B. and McCoy, K.D. (2012) Homeland Security: IgA immunity at the frontiers of the body. Trends Immunol 33, 160167.
  • Maldonado, G.C. and Perdigon, G. (2006) The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin Vaccine Immunol 13, 219226.
  • Marteau, P., Cuillerier, E., Meance, S., Gerhardt, M.F., Myara, A. and Bouvier, M. (2002) Bifidobacterium animalis strain DN-173010 shortens the colonic transit time in healthy women: a double blinded, randomized, controlled study. Aliment Pharmacol Ther 16, 587593.
  • Mathias, A. and Corthésy, B. (2011) Recognition of Gram-positive intestinal bacteria by hybridoma- and colostrum-derived secretory immunoglobulin A is mediated by carbohydrates. J Biol Chem 286, 1723917247.
  • Mathias, A., Longet, S. and Corthesy, B. (2013) Agglutinating Secretory IgA preserves intestinal epithelial cell integrity during apical infection by Shigella flexneri. Infect Immun 81, 30273034.
  • McClemens, J.M. (2011) The effect of Lactobacillus reuteri on host immune and cell alterations during an enteric parasitic infection. Open Access Dissertations and Theses. Paper 5893. McMaster University, Canada.
  • Mechoud, M.A., Mateos, M.V., de Valdez, G.F., Villena, J., Salvador, G.A. and Rodriguez, A.V. (2012) Lactobacillus reuteri CRL1098 soluble factors modulate tumor necrosis factor alpha production in peripheral blood mononuclear cells: involvement of lipid rafts. Int Immunopharmacol 14, 446453.
  • Miyauchi, E., O'Callaghan, J., Buttó, L.F., Hurley, G., Melgar, S., Tanabe, S., Shanahan, F., Nally, K. et al. (2012) Mechanism of protection of transepithelial barrier function by Lactobacillus salivarius: strain dependence and attenuation by bacteriocin production. Am J Physiol Gastrointest Liver Physiol 303, G1029G1041.
  • Moeini, H., Rahim, R.A., Omar, A.R., Shafee, N. and Yusoff, K. (2010) Lactobacillus acidophilus as a live vehicle for oral immunization against chicken anemia virus. Appl Microbiol Biotechnol 90, 7788.
  • Molloy, M., Bouladoux, N. and Belkaid, Y. (2012) Intestinal microbiota: shaping local and systemic immune responses. Semin Immunol 24, 5866.
  • Naidu, A.S., Bidlack, W.R. and Clemens, R.A. (1999) Probiotic spectra of lactic acid bacteria. Crit Rev Food Sci Nutr 39, 13126.
  • Otte, J.M. and Podolsky, D.K. (2004) Functional modulation of enterocytes by Gram-positive and Gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol 286, G613G626.
  • Ouwehand, A.C., DongLian, C., Weijian, X., Stewart, M., Ni, J., Stewart, T. and Miller, L.E. (2014) Probiotics reduce symptoms of antibiotic use in a hospital setting: a randomized dose response study. Vaccine 32, 458463.
  • Pabst, O. (2013) Trafficking of regulatory T cells in the intestinal immune system. Int Immunol 25, 139143.
  • Pedron, T. and Sansonetti, P. (2008) Commensals, bacterial pathogens and intestinal inflammation: an intriguing ménage à trois. Cell Host Microbe 3, 344347.
  • Peterson, D.A., McNulty, N.P., Guruge, J.L. and Gordon, J.I. (2007) IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe 2, 328339.
  • Poo, H., Pyo, H.M., Lee, T.Y., Yoon, S.W., Lee, J.S., Kim, C.J., Sung, M.H. and Lee, S.H. (2006) Oral administration of human papillomavirus type 16 E7 displayed on Lactobacillus casei induces E7-specific antitumor effects in C57/BL6 mice. Int J Cancer 119, 17021709.
  • Pruteanu, M. and Shanahan, F. (2013) Digestion of epithelial tight junction proteins by the commensal Clostridium perfringens. Am J Physiol Gastrointest Liver Physiol 305, G740G748.
  • Rajpal, S. and Kansal, V.K. (2009) Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum stimulates immune system in mice. Milchwissenschaft 64, 147150.
  • Reid, G., Jass, J., Sebulsky, M.T. and McCormick, J.K. (2003) Potential use of probiotics in clinical practice. Clin Microbiol Rev 16, 658672.
  • Remus, D.M., van Kranenburg, R., van Swam, I.I., Taverne, N., Bongers, R.S., Wels, M., Wells, J.M., Bron, P.A. et al. (2012) Impact of 4 Lactobacillus plantarum capsular polysaccharide clusters on surface glycan composition and host cell signaling. Microb Cell Fact 11, 149.
  • del Rio, B., Dattwyler, R.J., Aroso, M., Neves, V., Meirelles, L., Seegers, J.F. and Gomes-Solecki, M. (2008) Oral immunization with recombinant Lactobacillus plantarum induces a protective immune response in mice with Lyme disease. Clin Vaccine Immunol 15, 14291435.
  • Rizzello, V., Bonaccorsi, I., Dongarra, M.L., Fink, L.N. and Ferlazzo, G. (2011) Role of Natural Killer and Dendritic Cell crosstalk in immunomodulation by commensal bacteria probiotics. J Biomed Biotechnol 2011, 473097. doi:10.1155/2011/473097.
  • Rochereau, N., Drocourt, D., Perouzel, E., Pavot, V., Redelinghuys, P., Brown, G.D., Tiraby, G., Roblin, X. et al. (2013) Dectin-1 is essential for reverse transcytosis of glycosylated SIgA-Antigen complexes by intestinal M Cells. PLoS Biol 11, e1001658.
  • Rol, N., Favre, L., Benyacoub, J. and Corthesy, B. (2012) The role of Secretory Immunoglobulin A in the natural sensing of commensal bacteria by mouse Peyer's Patch Dendritic Cells. J Biol Chem 287, 4007440082.
  • Salzman, N.H., Hung, K., Haribhai, D., Chu, H., Karlsson-Sjoberg, J., Amir, E., Teggatz, P., Barman, M. et al. (2010) Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 11, 7683.
  • Scheppler, L., Vogel, M., Zuercher, A.W., Zuercher, M., Germond, J.E., Miescher, S.M. and Stadler, B.M. (2002) Recombinant Lactobacillus johnsonii as a mucosal vaccine delivery vehicle. Vaccine 20, 29132920.
  • Schlee, M., Wehkamp, J., Altenhoefer, A., Oelschlaeger, T.A., Stange, E.F. and Fellermann, K. (2007) Induction of human β-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infect Immun 75, 23992407.
  • Schlee, M., Harder, J., Koten, B., Stange, E.F., Wehkamp, J. and Fellerman, K. (2008) Probiotic lactobacilli and VSL#3 induce enterocyte beta defensin 2. Clin Exp Immunol 151, 528535.
  • Segawa, S., Nakakita, Y., Takata, Y., Wakita, Y., Kaneko, T., Kaneda, H., Watari, J. and Yasui, H. (2008) Effect of oral administration of heat-killed Lactobacillus brevis SBC8803 on total and ovalbumin-specific immunoglobulin E production through the improvement of Th1/Th2 balance. Int J Food Microbiol 121, 110.
  • Servin, A.L. (2004) Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 28, 405440.
  • Shalini, J., Yadav, H., Sinha, P.R., Kapila, S., Naito, Y. and Marotta, F. (2010) Anti-allergic effect of probiotic Dahi through modulation of the gut immune system. Turk J Gastroenterol 21, 244250.
  • Shimazu, T., Villena, J., Tohno, M., Fujie, H., Hosoya, S., Shimosato, T., Aso, H., Suda, Y. et al. (2012) Immunobiotic Lactobacillus jensenii elicit anti-inflammatory activity in porcine intestinal epithelial cells by modulating negative regulators of the toll-like receptor signaling pathway. Infect Immun 80, 276288.
  • Smelt, M.J., de Haan, B.J., Bron, P.A., van Swam, I., Meijerink, M., Wells, J.M., Faas, M.M. and de Vos, P. (2012) L. plantarum, L. salivarius, and L. lactis attenuate Th2 responses and increase Treg frequencies in healthy mice in a strain dependent manner. PLoS ONE 7, e47244.
  • Smelt, M.J., de Haan, B.J., Bron, P.A., van Swam, I., Meijerink, M., Wells, J.M., Kleerebezem, M., Fass, M.M. et al. (2013) The Impact of Lactobacillus plantarum WCFS1 Teichoic Acid D-Alanylation on the Generation of Effector and Regulatory T-cells in Healthy Mice. PLoS ONE 8, e63099.
  • Sun, J., Le, G.W., Shi, Y.H. and Su, G.W. (2007) Factors involved in binding of Lactobacillus plantarum Lp6 to rat small intestinal mucus. Lett Appl Microbiol 44, 7985.
  • Suzuki, K., Maruya, M., Kawamoto, S., Sitnik, K., Kitamura, H., Agace, W.W. and Fagarasan, S. (2010) The sensing of environmental stimuli by follicular dendritic cells promotes immunoglobulin A generation in the gut. Immunity 33, 7183.
  • Takeda, K. and Akira, S. (2004) TLR signaling pathways. Semin Immunol 16, 39.
  • Takeda, K., Suzuki, T., Shimada, S.I., Shida, K., Nanno, M. and Okumura, K. (2006) Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota. Clin Exp Immunol 146, 109115.
  • Thomas, M.C. and Versalovic, J. (2010) Probiotics-host communication: modulation of signaling pathways in the intestine. Gut Microbes 1, 148163.
  • Tien, M.T., Girardin, S.E., Regnault, B., Le Bourhis, L., Dillies, M.A., Coppee, J.Y., Bourdet-Sicard, R., Sansonetti, P.J. et al. (2006) Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol 176, 12281237.
  • Tobita, K., Yakana, H. and Otani, H. (2009) Heat-treated Lactobacillus crispatus KT strains reduce allergy symptoms in mice. J Agric Food Chem 57, 55865590.
  • Tobita, K., Yakana, H. and Otani, H. (2010) Lactobacillus crispatus k-11 enhances intestinal immune functions in C#H/HeN mice. J Nutr Sci Vitaminol 56, 441445.
  • Tsai, Y.T., Cheng, P.C., Fan, C.K. and Pan, T.M. (2008) Time-dependent persistence of enhanced immune response by a potential probiotic strain Lactobacillus paracasei subsp. paracasei NTU 101. Int J Food Microbiol 128, 219225.
  • Van Baarlen, P., Wells, J.M. and Kleerebezem, M. (2013) Regulation of intestinal homeostasis and immunity with probiotic lactobacilli. Trends Immunol 34, 208215.
  • Villena, J., Suzuki, R., Fujie, H., Chiba, E., Takahashi, T., Shimazu, T., Aso, H., Ohwada, S. et al. (2012) Immunobiotic Lactobacillus jensenii modulates toll-like receptor 4-induced inflammatory response via negative regulation in porcine antigen presenting cells. Clin Vaccine Immunol 19, 10381053.
  • Vissers, Y.M., Snel, J., Zuurendonk, P.F., Smit, B.A., Wichers, H.J. and Savelkoul, H.F. (2010) Differential effects of Lactobacillus acidophilus and Lactobacillus plantarum strains on cytokine induction in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 59, 6070.
  • Wang, Y., Xie, J., Wang, N., Li, Y., Sun, X., Zhang, Y. and Zhang, H. (2013) Lactobacillus casei Zhang modulate cytokine and Toll-like receptor expression and beneficially regulate poly I:C-induced immune responses in RAW264.7 macrophages. Microbiol Immunol 57, 5462.
  • Wehkamp, J., Harder, J., Wehkamp, K., Meissner, B.W., Schlee, M., Enders, C., Sonnenborn, U., Nuding, S. et al. (2004) NF-ĸB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun 72, 57505758.
  • Weiss, D.S., Raupach, B., Takeda, K., Akira, S. and Zychlinsky, A. (2004) Toll-like receptors are temporally involved in host defense. J Immunol 172, 44634469.
  • Wells, J.M., Rossi, O., Meijerink, M. and van Baarlen, P. (2011) Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci USA 108, 46074614.
  • Wen, K., Guohua, L., Tammy, B., Fangning, L., Yanru, L., Jacob, K., Lin, L., Xingdong, Y. et al. (2012a) High dose and low dose Lactobacillus acidophilus exerted differential immune modulating effects on T cell immune responses induced by an oral human rotavirus vaccine in gnotobiotic pigs. Vaccine 30, 11981207.
  • Wen, L.J., Hou, X.L., Wang, G.H., Yu, L.Y., Wei, X.M., Liu, J.K., Liu, Q. and Wei, C.H. (2012b) Immunization with recombinant Lactobacillus casei strains producing K99, K88 fimbrial protein protects mice against enterotoxigenic Escherichia coli. Vaccine 30, 33393349.
  • Ya, T., Zhang, Q., Chu, F., Merritt, J., Bilige, M., Sun, T., Du, R. and Zhang, H. (2008) Immunological evaluation of Lactobacillus casei Zhang: a newly isolated strain from koumiss in Inner Mongolia, China. BMC Immunol 9, 68.
  • Zhang, L., Li, N., Caicedo, R. and Neu, J. (2005) Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-a-induced interleukin-8 production in Caco-2 cells. J Nutr 135, 17521756.
  • Zhang, L.L., Chen, X., Zheng, P.Y., Luo, Y., Lu, G.F., Liu, Z.Q., Huang, H. and Yang, P.C. (2010) Oral Bifidobacterium modulates intestinal immune inflammation in mice with food allergy. J Gastroenterol Hepatol 25, 928934.